Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
393
datasets available to search
ShareScore release 0.9.0
Dataset results
393 results for “mRNA vaccine”
A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tum
ClinicalTrials.gov study NCT04847050. IPD Sharing: YES. Countries: 1. Publications: 0.
Study to Evaluate Safety and Immunogenicity of a Pandemic Flu H5 mRNA Vaccine in Healthy Adults Aged 18 Years and Older
ClinicalTrials.gov study NCT06727058. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study to Investigate the Safety and Immunogenicity of the Quadrivalent Influenza mRNA Vaccines in Adults Aged 18 Years and Above
ClinicalTrials.gov study NCT06361875. IPD Sharing: YES. Countries: 3. Publications: 0.
Phase 1/2 Study of Chlamydia Trachomatis mRNA Vaccine in Adults Aged 18 to 29 Years
ClinicalTrials.gov study NCT06891417. IPD Sharing: YES. Countries: 1. Publications: 0.
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
ClinicalTrials.gov study NCT06316297. IPD Sharing: YES. Countries: 3. Publications: 0.
Study to Assess the Safety and Immunogenicity of Monovalent mRNA NA Vaccine in Adult Participants 18 Years of Age and Older
ClinicalTrials.gov study NCT05426174. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults
ClinicalTrials.gov study NCT05415462. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5413 in Adult Participants18 Years of Age and Older
ClinicalTrials.gov study NCT05650554. IPD Sharing: YES. Countries: 3. Publications: 0.
Study of a Human Metapneumovirus/Respiratory Syncytial Virus mRNA Vaccine Candidate Encapsulated in a Lipid Nanoparticle-based Formulation in Adults Aged 60 Years and Older
ClinicalTrials.gov study NCT06686654. IPD Sharing: YES. Countries: 1. Publications: 0.
This Study Intends to Describe the Characteristics of Patients Given the Pfizer-BioNTech Bivalent mRNA COVID-19 Vaccine and Any Commercially Available Influenza Vaccines at the Same Time Versus at Dif
ClinicalTrials.gov study NCT05858450. IPD Sharing: NO. Countries: 1. Publications: 0.
A Safety and Immune Response Study to Evaluate Varying Doses of an mRNA Vaccine Against Coronavirus Disease 2019 (COVID-19) in Healthy Adults
ClinicalTrials.gov study NCT05972993. IPD Sharing: YES. Countries: 1. Publications: 0.
Comparative Immunogenicity of Concomitant vs Sequential mRNA COVID-19 and Influenza Vaccinations
ClinicalTrials.gov study NCT06020118. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Zika Vaccine mRNA-1893 in Adult Participants Living in Endemic and Non-Endemic Flavivirus Areas
ClinicalTrials.gov study NCT04917861. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes
ClinicalTrials.gov study NCT06033261. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of an Investigational mRNA-1273.815 COVID-19 Vaccine in Previously Vaccinated Adults
ClinicalTrials.gov study NCT06354998. IPD Sharing: NO. Countries: 1. Publications: 0.
COVID-19: A Study to Evaluate Safety, Reactogenicity and Immunogenicity of the SARS-CoV-2 mRNA Vaccine CVnCoV in Adults With Co-morbidities
ClinicalTrials.gov study NCT04860258. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a COVID-19 mRNA Vaccine in Adults Aged 50 Years and Above
ClinicalTrials.gov study NCT06374394. IPD Sharing: YES. Countries: 4. Publications: 0.
Study to Evaluate the Safety and the Immunogenicity of a Second Generation Structurally Designed mRNA Vaccine Candidate Against Pandemic Influenza H5 HA Strain in Healthy Adult Participants Aged 18 Ye
ClinicalTrials.gov study NCT06907511. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study to Investigate Cardiac Troponin Levels After mRNA-1273.712 Vaccine in Participants 12 Through 30 Years of Age
ClinicalTrials.gov study NCT06634797. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (COVI
ClinicalTrials.gov study NCT05119855. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.